Trials / Completed
CompletedNCT02326376
Kineret CAPS Post Authorisation Study
Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Swedish Orphan Biovitrum · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A non-interventional, post authorization safety study to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serious infections, malignancies, injection site reactions, allergic reactions and medication errors, including re-use of syringe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anakinra (Kineret) |
Timeline
- Start date
- 2015-04-24
- Primary completion
- 2019-09-12
- Completion
- 2019-09-12
- First posted
- 2014-12-29
- Last updated
- 2020-01-18
Locations
2 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02326376. Inclusion in this directory is not an endorsement.